BPMC

Blueprint Medicines

Delisted

BPMC was delisted on the 17th of July, 2025.

278 hedge funds and large institutions have $6.29B invested in Blueprint Medicines in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 97 increasing their positions, 108 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

14% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 35

20% less call options, than puts

Call options by funds: $9.29M | Put options by funds: $11.7M

25% less funds holding in top 10

Funds holding in top 10: 86 (-2)

Holders
278
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9.29M
Puts
$11.7M
Net Calls
Net Calls Change

Top Sellers

1 -$92.5M
2 -$64.4M
3 -$43M
4
Deutsche Bank
Deutsche Bank
Germany
-$24.3M
5
Goldman Sachs
Goldman Sachs
New York
-$22.8M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$593M
2
$572M
3
$487M
4
$372M
5
$252M
6
$187M
7
$185M
8
$176M
9
$166M
10
$161M
11
$149M
12
$137M
13
$136M
14
$118M
15
$114M
16
$110M
17
$107M
18
$102M
19
$93.9M
20
$92.6M
21
$92.1M
22
$86.9M
23
$86.4M
24
$73.4M
25
$69.1M